Author:
Golimbet V. E.,Volel’ B. A.,Korovaitseva G. I.,Kasparov S. V.,Kondrat’ev N. V.,Kopylov F. Yu.
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. D. M. Moreira, R. L. da Silva, J. L. Vieira, T. Fattah, M. E. Lueneberg, and C. A. Gottschall, “Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease,” Am. J. Cardiovasc. Drugs, 15, No. 1, 1–11 (2015), doi:
https://doi.org/10.1007/s40256-014-0094-z
.
2. A. S. Tiganov, G. I. Kopeiko, O. S. Brusov, and T. P. Klyushnik, “A new study of the pathogenesis and treatment of endogenous depression,” Zh. Nevrol. Psikhiatr. im. S. S. Korsakova, 112, No. 11, 65–72 (2012).
3. N. Yu. Shimokhina, A. A. Savchenko, M. M. Petrova, and M. S. Chernyaeva (Pilyugina), “The state of the hemostasis and immune systems in patients with acute coronary syndrome combined with anxious-depressive disorders,” Kardiologiya, 55, No. 8, 12–20 (2015).
4. N. G. Neznanov, S. N. Kozlova, G. E. Mazo, E. V. Shlyakhto, and B. I. Smirnov, “Comorbidity of depressive disorders with ischemic heart disease: common aspects of pathogenesis,” Zh. Nevrol. Psikhiatr. im. S. S. Korsakova, 115, No. 5, 20–26 (2015).
5. N. Nikkheslat, P. A. Zunszain, M. A. Horowitz, I. G. Barbosa, J. A. Par ker, A. M. Myint, M. J. Schwarz, A. T. Tylee, L. A. Carvalho, and C. M. Pariante, “Insufficient glucocorticoid signaling and elevated inflammation in coronary heart disease patients with comorbid depression,” Brain Behav. Immun. (2015), pii: S0889-1591(15) 00020-3, doi:
https://doi.org/10.1016/j.bbi.2015.02.002
.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献